Skip to main content

Table 1 NIS mRNA levels do not vary among human breast tumors as detected by oligonucleotide microarray technology

From: Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer

Microarray Platform NIS Probe Set ID Probe Length Target (NIS Sequence) Standard Deviation
Affymetrix HG U133 Plus 2.0 211123_at 25-mer (n* = 11) 5'-1521-1991-3' Avg. 0.23, Range 0.17-0.28 (N# = 2)
Affymetrix HG U95A 32459_at 25-mer (n* = 16) 5'-1522-1998-3' Avg. 0.20, Range 0.14-0.26 (N# = 2)
Affymetrix Human X3P G2887404_3p_at 25-mer (n* = 11) 5'-1693-1992-3' Avg. 0.18, Range 0.18-0.18 (N# = 2)
Applied Biosystems Human Survey Microarray V1 193100 60-mer (n* = 1) Proprietary 0.21 (N# = 1)
Agilent-012391 Human Genome 30047 60-mer (n* = 1) 5'-1707-1767-3' 0.13 (N# = 1)
  1. *, Number of perfect match oligonucleotide probes within the NIS probe set.
  2. #, Number of datasets examined that utilized each respective microarray platform.